## 

|Reports||
|---|---|
|Referenceandadministrativeinformation|1|
|Trustees'report|2|
|Independentauditor'sreport|18|



|Financialstatements||
|---|---|
|Statementoffinancialactivities|22|
|Balancesheet|23|
|Statementofcashflows|24|
|Principalaccountingpolicies|25|
|Notestothefinancialstatements|29|





## 

|Trustees|JamesCarleton|
|---|---|
||MarkClarke|
||MichaelMoody|
|ChiefExecutiveandCompanySecretary|RichardPierce-Saunderson|
|Registeredoffice|66Lincoln'sInnFields|
||`London`|
||WC2A3LH|
|Companyregistrationnumber|05718135(EnglandandWales)|
|Charityregistrationnumber|`1113064`|
|Auditors|BuzzacottLLP|
||130WoodStreet|
||`London`|
||EC2V6DL|
|Bankersandinvestmentmanagers|CHoare&Co|
||37FleetStreet|
||`London`|
||EC4P4DQ|
||UBSWealthManagement|
||1FinsburyAvenue|
||`London`|
||EC2M2AN|
||InvestecWealth&InvestmentLimited|
||2GreshamStreet|
||`London`|
||EC2V7QN|
|Solicitors|Farrer&CoLLP|
||66Lincoln'sInnFields|
||`London`|
||WC2A3LH|
|Website|www.thefebruaryfoundation.org|





## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 



## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



James Carleton 



## 

## 

## 

## 



## 

## 



## 




26 November 2021 




## 

|||Unrestricted|Expendable|<br>Total|Unrestricted|Expendable|<br>Total|
|---|---|---|---|---|---|---|---|
|||funds|endowment|<br>2021|funds|<br>endowment|<br>2020|
||Notes|<br>£|<br>£|£|£|<br>£|<br>£|
|Incomefrom:||||||||
|Donations||—|2,946,269|2,946,269|—|2,471,105|2,471,105|
|`Giftofshares`|`6`|`—`|`10,596,000`|`10,596,000`|`—`|`10,690,000`|<br>`10,690,000`|
|Investments|1|4,042,771|—|4,042,771|4,046,113|—|4,046,113|
|Totalincome||4,042,771|13,542,269|17,585,040|4,046,113|13,161,105|17,207,218|
|Expenditureon:||||||||
|Investmentmanagementcosts||—|103,823|103,823|—|84,363|84,363|
|Charitableactivities|2|2,470,567|9,336,000|11,806,567|2,256,365|10,480,000|12,736,365|
|Totalexpenditure||2,470,567|9,439,823|11,910,390|2,256,365|10,564,363|12,820,728|
|Netincomebefore(losses)gains||||||||
|`oninvestments`||`1,572,204`|`4,102,446`|`5,674,650`|`1,789,748`|<br>`2,596,742`|`4,386,490`|
|Net(losses)gainsoninvestments|6|||||||
|• Realisedonsale||—|(3,882,697)|(3,882,697)|—|(113,963)|<br>(113,963)|
|• Unrealised:changesinmarketvalue||—|(6,278,762)|(6,278,762)|—|7,883,016|7,883,016|
|||—|(10,161,459)|(10,161,459)|—|7,769,053|7,769,053|
|Netincomeandnetmovementin||||||||
|fundsfortheyear||1,572,204|(8,059,013)|(4,486,809)|1,789,748|10,365,795|12,155,543|
|Fundbalancesbroughtforwardat||||||||
|1March2020||13,386,815|108,613,210|122,000,025|11,597,067|98,247,415|109,844,482|
|Fundbalancescarriedforwardat||||||||
|28February2021||14,959,019|102,554,197|117,513,216|13,386,815|108,613,210|122,000,025|





James Carleton 



## 

|||`2021`|`2020`|
|---|---|---|---|
||Notes|£|£|
|Cashflowsfromoperatingactivities:||||
|Netcashprovidedby(usedin)operatingactivities|A|415,295|(9,022)|
|Cashflowsfrominvestingactivities:||||
|Dividendsandinterestfrominvestments||4,056,927|4,016,708|
|Proceedsfromthedisposalofinvestments||7,816,488|1,719,927|
|Purchaseofinvestments||(8,681,547)|(9,315,338)|
|Netcashprovidedby(usedin)investingactivities||3,191,868|(3,578,703)|
|Changeincashandcashequivalentsintheyear||3,607,163|(3,587,725)|
|Cashandcashequivalentsat1March2020|B|2,315,523|5,903,248|
|Cashandcashequivalentsat29February2021|B|5,922,686|2,315,523|
|Notestothestatementofcashflows||||



|A|Reconciliationofnetmovementinfundstonetcashprovidedby(usedin)operating|Reconciliationofnetmovementinfundstonetcashprovidedby(usedin)operating|Reconciliationofnetmovementinfundstonetcashprovidedby(usedin)operating|
|---|---|---|---|
||activities|||
|||`2021`|`2020`|
|||`£`|`£`|
||Netincome(asperthestatementoffinancialactivities)|(4,486,809)|12,155,543|
||Adjustmentsfor:|||
||Loss(gains)oninvestments|10,161,459|(7,769,053)|
||Dividendsandinterestfrominvestments|(4,042,771)|(4,046,113)|
||Giftofshares:netmovementonsharesreceivedanddonated|(1,260,000)|(210,000)|
||Decrease(increase)indebtors|112,720|(111,480)|
||Decreaseincreditors|(69,305)|(27,919)|
||Netcashprovidedby(usedin)operatingactivities|415,4295|(9,022)|
|B|Analysisofcashandcashequivalents|||
|||`2021`|`2020`|
|||`£`|`£`|
||Cashatbankandinhand|5,186,409|500,901|
||Cashheldbyinvestmentmanagers(note6)|736,277|1,814,622|
||Totalcashandcashequivalents|5,922,686|2,315,523|





## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

|Investmentincome|||
|---|---|---|
||`2021`|`2020`|
||`£`|`£`|
|Dividendsandinterestinvestments|4,029,211|4,023,644|
|Interestoncashholdings|13,560|22,669|
||4,042,771|4,046,313|



## 

|Expenditureoncharitableactivities|||
|---|---|---|
||`2021`|`2020`|
||`£`|<br>`£`|
|Grantspaidtoinstitutionsbycategory|||
|• Education|204,579|612,144|
|• Heritage|—|50,000|
|• Healthcareandpatientsupport|1,027,258|829,813|
|End-of-lifecare|782,186|437,844|
|• Othercategories|393,953|195,875|
|Totalgrantspaidintheyear|2,407,976|2,125,676|
|Releaseofprioryeargrantcommitments|(69,630)|—|
|Totalgrantspayable|2,338,346|2,125,676|
|• Investmentsdonatedtoaregisteredcharity|9,336,000|10,480,000|
||11,681,517|12,605,676|
|GrantandFoundationadministrative expensesincludinggovernance|||
|costs(note3)|132,221|130,689|
||11,806,567|12,736,365|



|Governancecosts|||
|---|---|---|
||`2021`|`2020`|
||`£`|`£`|
|Feespayabletotheauditor:|||
|Statutoryaudit|12,059|12,240|
|Taxationservices|3,268|7,288|
|Payrollservices|2,686|2,688|
||18,013|22,216|





||`2021`|`2020`|
|---|---|---|
||`£`|`£`|
|Staffcostscomprise:|||
|Wagesandsalaries|87,000|83,140|
|Socialsecuritycosts|7,673|10,588|
|Pensioncosts|6,525|6,400|
|Medicalinsurance|7,171|1,463|
||108,369|101,591|



## 

## 



## 

## 

|Fixedassetinvestments<br>Attheyearend,fixedassetinvestmentscomprisedthefollow<br>investment:|inginvestment|sandcashfor|
|---|---|---|
||Total|<br>Total|
||`2021`|<br>`2020`|
||`£`|<br>`£`|
|Marketvalueofinvestmentsat1March2020|119,658,838|104,084,374|
|Giftofsharesreceived|10,596,000|10,690,000|
|Additions|8,681,547|<br>9,315,338|
|Disposals(proceeds£7,816,488:realisedlosses£3,882,697)|(11,699,185)|(1,833,890)|
|Disposals:SharesdonatedtoaUKcharityatmarketvalue(note2)|9,336,000|(10,480,000)|
|Unrealised(losses)gainsintheyear|(6,278,762)|<br>7,883,016|
|Marketvalueofinvestmentsat28February2021|111,622,438|119,658,838|
|Cashheldforreinvestment|736,277|<br>1,814,622|
||112,358,715|121,473,460|
|Historiccostofinvestmentsat28February2021|87,623,924|23,572,758|
|Themarketvalueofinvestmentsat28February2021comprises:|||
|UKlisted|93,012,750|104,288,203|
|UKfixedintereststock|7,402,096|<br>8,239,206|
|Overseaslisted|8,043,123|<br>4,471,091|
|Overseasfixedinterest|367,355|<br>185,780|
|Alternatives|990,305|<br>546,079|
|Property|1,806,809|1,928,479|
|Cashheldforreinvestment|736,277|1,814,622|
||112,356,715|121,473,460|



## 

|.Debtors|||
|---|---|---|
||`2021`|`2020`|
||£|£|
|Duewithinoneyear|||
|Accruedinvestmentincome|57,243|71,400|
|Prepayments|—|787|
|Otherdebtors|—|111,933|
||57,243|184,120|





## 

## 

|Creditors||||
|---|---|---|---|
|||`2021`|<br>`2020`|
|||`£`|<br>`£`|
|Duewithinoneyear||||
|`Accruedexpenses`||`31,655`|<br>`31,326`|
|Grantspayable||32,500|72,130|
|||64,151|103,456|
|Dueaftermorethanoneyear||||
|Grantspayable||25,000|55,000|
|Totalcreditors||89,154|158,456|
|At28February2021,grantsof£57,500(2020-£127,130)hadbeenapprovedanda||||
|conditionshadbeensatisfied.InaccordancewiththeFoundation'saccountingpolicy,thes||||
|amountshavebeenrecognisedasaliabilityin|thebalancesheet.|||
|Analysisofnetassetsbetweenfunds||||
||ExpendableUnrestricted||Total|
||endowment|funds|2021|
||`£`|`£`|`£`|
|Fundbalancesat28February2021||||
|arerepresentedby:||||
|Investments|102,554,197|9,804,518|112,358,715|
|Currentassets|—|5,243,652|5,243,652|
|Creditors:amountsfallingduewithinoneyear|—|(64,151)|(64,151)|
|Creditors:amountsfallingdueafteroneyear|—|(25,000)|(25,000)|
|Totalnetassets|102,554,19714,959,019||117,513,216|
||ExpendableUnrestricted||Total|
||endowment|funds|2020|
||`£`|`£`|`£`|
|Fundbalancesat28February2020||||
|arerepresentedby:||||
|Investments|108,613,21012,860,250||121,473,460|
|Currentassets|`-`|`685,021`|`685,021`|
|Creditors:amountsfallingduewithinoneyear|-|(103,456)|(103,456)|
|Creditors:amountsfallingdueafteroneyear|-|(55,000)|(55,000)|
|Totalnetassets|108,613,21013,386,815||122,000,025|



## 



## 

|||Healthcare|End-of-|||
|---|---|---|---|---|---|
|||andpatient|Life|||
||Education|support|Care|Other|Total|
||£|£|£|£|£|
|Maximumcommitmentat||||||
|1March2020|1,546,274|1,251,920|160,000|125,000|3,083,194|
|Paidinyear|(204,580)|(555,000)|(67,500)|(25,000)|(852,080)|
|Newcommitments|1,223,306|467,972|(32,500)|-|1,658,778|
|Maximumcommitmentat||||||
|28February2021|2,565,000|1,164,892|60,000|100,000|3,889,892|



|||Healthcare|End-of-|||
|---|---|---|---|---|---|
|||andpatient|Life|||
||Education|support|Care|Other|Total|
||£|£|£|£|£|
|Maximumcommitmentat||||||
|1March2019|192,558|1,135,000|30,000|50,000|1,407,558|
|Paidinyear||||||
|.Actual|(220,204)|(579,000)|(15,000)|(25,000)|(839,204)|
|Newcommitments|1,573,920|695,920|160,000|100,000|2,519,840|
|Maximumcommitmentat||||||
|29February2020|1,546,274|1,251,920|160,000|125,000|3,083,194|



## 



## 

## 




|Reports||
|---|---|
|Referenceandadministrativeinformation|1|
|Trustees'report|2|
|Independentauditor'sreport|18|
|Financialstatements||
|Statementoffinancialactivities|22|
|Balancesheet|23|
|Statementofcashflows|24|
|Principalaccountingpolicies|25|
|Notestothefinancialstatements|29|





## 

|Trustees|JamesCarleton|
|---|---|
||MarkClarke|
||MichaelMoody|
|ChiefExecutiveandCompanySecretary|RichardPierce-Saunderson|
|Registeredoffice|66Lincoln'sInnFields|
||`London`|
||WC2A3LH|
|Companyregistrationnumber|05718135(EnglandandWales)|
|Charityregistrationnumber|`1113064`|
|Auditors|BuzzacottLLP|
||130WoodStreet|
||`London`|
||EC2V6DL|
|Bankersandinvestmentmanagers|CHoare&Co|
||37FleetStreet|
||`London`|
||EC4P4DQ|
||UBSWealthManagement|
||1FinsburyAvenue|
||`London`|
||EC2M2AN|
||InvestecWealth&InvestmentLimited|
||2GreshamStreet|
||`London`|
||EC2V7QN|
|Solicitors|Farrer&CoLLP|
||66Lincoln'sInnFields|
||`London`|
||WC2A3LH|
|Website|www.thefebruaryfoundation.org|





## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 



## 

|||Unrestricted|Expendable|<br>Total|Unrestricted|Expendable|<br>Total|
|---|---|---|---|---|---|---|---|
|||funds|endowment|<br>2021|funds|<br>endowment|<br>2020|
||Notes|<br>£|<br>£|£|£|<br>£|<br>£|
|Incomefrom:||||||||
|Donations||—|2,946,269|2,946,269|—|2,471,105|2,471,105|
|Giftofshares|6|—|10,596,000|10,596,000|—|10,690,000|10,690,000|
|Investments|1|4,042,771|—|4,042,771|4,046,113|—|4,046,113|
|Totalincome||4,042,771|13,542,269|17,585,040|4,046,113|13,161,105|17,207,218|
|Expenditureon:||||||||
|Investmentmanagementcosts||—|103,823|103,823|—|84,363|84,363|
|Charitableactivities|2|2,470,567|9,336,000|11,806,567|2,256,365|10,480,000|12,736,365|
|Total expenditure||2,470,567|9,439,823|11,910,390|2,256,365|10,564,363|12,820,728|
|Netincomebefore(losses)gains||||||||
|oninvestments||1,572,204|4,102,446|5,674,650|1,789,748|2,596,742|4,386,490|
|Net(losses)gainsoninvestments|6|||||||
|• Realisedonsale||—|(3,882,697)|(3,882,697)|—|(113,963)|<br>(113,963)|
|• Unrealised:changesinmarketvalue||—|(6,278,762)|(6,278,762)|—|7,883,016|7,883,016|
|||—|(10,161,459)|(10,161,459)|—|7,769,053|7,769,053|
|Netincomeandnetmovementin||||||||
|fundsfortheyear||1,572,204|(8,059,013)|(4,486,809)|1,789,748|10,365,795|12,155,543|
|Fundbalancesbroughtforwardat||||||||
|1March2020||13,386,815|108,613,210|122,000,025|11,597,067|98,247,415|109,844,482|
|Fundbalancescarriedforwardat||||||||
|28February2021||14,959,019|102,554,197|117,513,216|13,386,815|108,613,210|122,000,025|





|||`2021`|`2021`|`2020`|<br>`2020`|
|---|---|---|---|---|---|
||Notes|£|£|£|£|
|Fixedassets||||||
|Investments|6||112,358,715||121,473,460|
|Currentassets||||||
|Debtors|7|57,243||184,120||
|Cashatbankandinhand||5,186,409||500,901||
|||5,243,652||685,021||
|Currentliabilities||||||
|Creditors:amountsfallingdue||||||
|withinoneyear|8|(64,151)||(103,456)||
|Netcurrentassets|||5,179,501||581,565|
|Totalassetslesscurrent||||||
|liabilities|||117,538,216||122,055,025|
|Non-currentliabilities||||||
|Creditors:amountsfallingdue|8|||||
|afteroneyear|||(25,000)||(55,000)|
|Netassets|||117,513,216||122,000,025|
|ThefundsoftheFoundation|9|||||
|Fundsandreserves||||||
|Capitalfunds||||||
|Expendableendowment|||102,554,197||108,613,210|
|Incomefunds||||||
|Unrestrictedfunds|||14,959,019||13,386,815|
||||117,513,216||122,000,025|
|Approvedbythetrustees||||||
|andsignedontheirbehalfby:||||||






## 

|||`2021`|`2020`|
|---|---|---|---|
||Notes|£|£|
|Cashflowsfromoperatingactivities:||||
|Netcashprovidedby(usedin)operatingactivities|A|415,295|(9,022)|
|Cashflowsfrominvestingactivities:||||
|Dividendsandinterestfrominvestments||4,056,927|4,016,708|
|Proceedsfromthedisposalofinvestments||7,816,488|1,719,927|
|Purchaseofinvestments||(8,681,547)|(9,315,338)|
|Netcashprovidedby(usedin)investingactivities||3,191,868|(3,578,703)|
|Changeincashandcashequivalentsintheyear||3,607,163|(3,587,725)|
|Cashandcashequivalentsat1March2020|B|2,315,523|5,903,248|
|Cashandcashequivalentsat29February2021|B|5,922,686|2,315,523|
|Notestothestatementofcashflows||||



|A|Reconciliationofnetmovementinfundstonetcashprovidedby(usedin)operating|Reconciliationofnetmovementinfundstonetcashprovidedby(usedin)operating|Reconciliationofnetmovementinfundstonetcashprovidedby(usedin)operating|
|---|---|---|---|
||activities|||
|||`2021`|`2020`|
|||`£`|`£`|
||Netincome(asperthestatementoffinancialactivities)|(4,486,809)|12,155,543|
||Adjustmentsfor:|||
||Loss(gains)oninvestments|10,161,459|(7,769,053)|
||Dividendsandinterestfrominvestments|(4,042,771)|(4,046,113)|
||Giftofshares:netmovementonsharesreceivedanddonated|(1,260,000)|(210,000)|
||Decrease(increase)indebtors|112,720|(111,480)|
||Decreaseincreditors|(69,305)|(27,919)|
||Netcashprovidedby(usedin)operatingactivities|415,4295|(9,022)|
|B|Analysisofcashandcashequivalents|||
|||`2021`|`2020`|
|||`£`|`£`|
||Cashatbankandinhand|5,186,409|500,901|
||Cashheldbyinvestmentmanagers(note6)|736,277|1,814,622|
||Totalcashandcasheauivalents|5,922,686|2,315,523|





## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

|1|Investmentincome|||
|---|---|---|---|
|||`2021`|`2020`|
|||`£`|<br>`£`|
||Dividendsandinterestinvestments|4,029,211|4,023,644|
||Interestoncashholdings|13,560|22,669|
|||4,042,771|4,046,313|
|2|Expenditureoncharitableactivities|||
|||`2021`|`2020`|
|||`£`|`£`|
||Grantspaidtoinstitutionsbycategory:|||
||• Education|204,579|612,144|
||• Heritage|—|50,000|
||• Healthcareandpatientsupport|1,027,258|829,813|
||• End-of-lifecare|782,186|437,844|
||Othercategories|393,953|195,875|
||Totalgrantspaidintheyear|2,407,976|2,125,676|
||Releaseofprioryeargrantcommitments|(69,630)|—|
||Totalgrantspayable|2,338,346|2,125,676|
||Investmentsdonatedtoaregisteredcharity|9,336,000|10,480,000|
|||11,681,517|12,605,676|
||GrantandFoundationadministrativeexpensesincludinggovernance|||
||costs(note3)|132,221|130,689|
|||11,806,567|12,736,365|



|3|Governancecosts|||
|---|---|---|---|
|||`2021`|`2020`|
|||`£`|`£`|
||Feespayabletotheauditor:|||
||Statutoryaudit|12,059|12,240|
||Taxationservices|3,268|7,288|
||Payrollservices|2,686|2,688|
|||18,013|22,216|





## 

## 

||`2021`|`2020`|
|---|---|---|
||`£`|`£`|
|Staffcostscomprise:|||
|Wagesandsalaries|87,000|83,140|
|Socialsecuritycosts|7,673|10,588|
|Pensioncosts|6,525|6,400|
|Medicalinsurance|7,171|1,463|
||108,369|101,591|



## 



## 

## 

||Total|<br>Total|
|---|---|---|
||`2021`|<br>`2020`|
||`£`|<br>`£`|
|Marketvalueofinvestmentsat1March2020|119,658,838|104,084,374|
|Giftofsharesreceived|10,596,000|10,690,000|
|Additions|8,681,547|<br>9,315,338|
|Disposals(proceeds£7,816,488:realisedlosses£3,882,697)|(11,699,185)|(1,833,890)|
|Disposals:SharesdonatedtoaUKcharityatmarketvalue(note2)|9,336,000|(10,480,000)|
|Unrealised(losses)gainsintheyear|(6,278,762)|<br>7,883,016|
|Marketvalueofinvestmentsat28February2021|111,622,438|119,658,838|
|Cashheldforreinvestment|736,277|<br>1,814,622|
||112,358,715|121,473,460|
|Historiccostofinvestmentsat28February2021|87,623,924|23,572,758|
|Themarketvalueofinvestmentsat28February2021comprises|||
|UKlisted|93,012,750|104,288,203|
|UKfixedintereststock|7,402,096|8,239,206|
|Overseaslisted|8,043,123|<br>4,471,091|
|Overseasfixedinterest|367,355|185,780|
|Alternatives|990,305|546,079|
|Property|1,806,809|1,928,479|
|Cashheldforreinvestment|736,277|1,814,622|
||112,356,715|121,473,460|



## 

|.Debtors|||
|---|---|---|
||`2021`|`2020`|
||£|£|
|Duewithinoneyear|||
|Accruedinvestmentincome|57,243|71,400|
|Prepayments|—|787|
|Otherdebtors|—|111,933|
||57,243|184,120|





## 

## 

|Creditors||||
|---|---|---|---|
|||`2021`|`2020`|
|||`£`|<br>`£`|
|Duewithinoneyear||||
|Accruedexpenses||`31,655`|<br>`31,326`|
|Grantspayable||32,500|72,130|
|||64,151|103,456|
|Dueaftermorethanoneyear||||
|Grantspayable||25,000|55,000|
|Totalcreditors||89,154|158,456|
|At28February2021,grantsof£57,500(2020-£127,130)hadbeenapprovedanda||||
|conditionshadbeensatisfied.InaccordancewiththeFoundation's accountingpolicy,thes||||
|amountshavebeenrecognisedasaliabilityin|thebalancesheet.|||
|Analysisofnetassetsbetweenfunds||||
||ExpendableUnrestricted||Total|
||endowment|funds|2021|
||`£`|`£`|`£`|
|Fundbalancesat28February2021||||
|arerepresentedby:||||
|Investments|102,554,197|9,804,518|112,358,715|
|Currentassets|—|5,243,652|5,243,652|
|Creditors:amountsfallingduewithinoneyear|—|(64,151)|(64,151)|
|Creditors:amountsfallingdueafteroneyear|—|(25,000)|(25,000)|
|Totalnetassets|102,554,19714,959,019||117,513,216|
||ExpendableUnrestricted||Total|
||endowment|funds|2020|
||`£`|`£`|`£`|
|Fundbalancesat28February2020||||
|arerepresentedby:||||
|Investments|108,613,21012,860,250||121,473,460|
|Currentassets|`-`|`685,021`|`685,021`|
|Creditors:amountsfallingduewithinoneyear|-|(103,456)|(103,456)|
|Creditors:amountsfallingdueafteroneyear|-|(55,000)|(55,000)|
|Totalnetassets|108,613,21013,386,815||122,000,025|



## 



## 

## 

|||Healthcare|End-of-|||
|---|---|---|---|---|---|
|||andpatient|Life|||
||Education|support|Care|Other|Total|
||£|£|£|£|£|
|Maximumcommitmentat||||||
|1March2020|1,546,274|1,251,920|160,000|125,000|3,083,194|
|Paidinyear|(204,580)|(555,000)|(67,500)|(25,000)|(852,080)|
|Newcommitments|1,223,306|467,972|(32,500)|—|1,658,778|
|Maximumcommitmentat||||||
|28February2021|2,565,000|1,164,892|60,000|100,000|3,889,892|
|||Healthcare|End-of-|||
|||andpatient|Life|||
||Education|support|Care|Other|Total|
||£|£|£|£|£|
|Maximumcommitmentat||||||
|1March2019|192,558|1,135,000|30,000|50,000|1,407,558|
|Paidinyear||||||
|.Actual|(220,204)|(579,000)|(15,000)|(25,000)|(839,204)|
|Newcommitments|1,573,920|695,920|160,000|100,000|2,519,840|
|Maximumcommitmentat||||||
|29February2020|1,546,274|1,251,920|160,000|125,000|3,083,194|



##